← Open Payments lookup

JESSICA HARMS: Open Payments

NPI 1487078135 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,300 in 77 payments from 17 companies in 2025. Trend: 2023 $17 · 2024 $881 · 2025 $1,300

Food & beverage: $1,300
CompanyPaymentsAmount
ABBVIE INC.29$346
Otsuka America Pharmaceutical, Inc.17$283
Janssen Pharmaceuticals, Inc5$200
E.R. Squibb & Sons, L.L.C.5$74
Takeda Pharmaceuticals U.S.A., Inc.3$58
Vanda Pharmaceuticals Inc.2$44
Biogen, Inc.2$39
Teva Pharmaceuticals USA, Inc.2$35
Noven Therapeutics, LLC2$34
SANOFI-AVENTIS U.S. LLC2$32

Products named: VRAYLAR, REXULTI, SPRAVATO, COBENFY, ABILIFY MAINTENA, TRINTELLIX, FANAPT, ZURZUVAE.

Industry payments across NE — which companies pay providers there.